Clinical Trial Update: Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluated NRL972 when administered with ursodeoxycholic acid and cloxacillin in individuals with hepatic cirrhosis; the trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Cirrhosis

Drugs mentioned

• NRL972 (NRL972)
• Ursodeoxycholic acid (ursodeoxycholic acid)
• cloxacillin (cloxacillin)

Snippet

Sponsor: Norgine | Conditions: Hepatic Cirrhosis | Phase 1 | Status: COMPLETED